
-
GSK NEW YORK STOCK EXCHANGE INC.:GSK GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Location: G S K House, 980 Great West Road, Middlesex, TW8 9GS, United Kingdom | Website: www.gsk.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
161.1B
Cash
4.326B
Avg Qtr Burn
N/A
Short % of Float
0.44%
Insider Ownership
0.06%
Institutional Own.
17.05%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Jesduvroq (Daprodustat) Details Chronic kidney disease | Approved Quarterly sales | |
Approved Quarterly sales | ||
Ojjaara (Momelotinib) (JAK Inhibitor) Details Myelofibrosis | Approved Quarterly sales | |
Blujepa (Gepotidacin) Details Urinary tract infection | Approved Quarterly sales | |
Arexvy Details Viral infection, Respiratory syncytial virus, Vaccine | Approved Quarterly sales | |
Jemperli (dostarlimab) Details Endometrial cancer, Cancer | Approved Quarterly sales | |
Jemperli (dostarlimab) Details Cancer, Endometrial cancer | Approved Quarterly sales | |
Linerixibat Details Primary biliary cholangitis | Phase 3 Data readout | |
Depemokimab Details Chronic rhinosinusitis with nasal polyps | Phase 3 Data readout | |
Bepirovirsen Details Hepatitis B vaccine | Phase 3 Data readout | |
BLU-5937 (P2X3 antagonist) Details Chronic cough | Phase 3 Data readout | |
Nucala Details Chronic obstructive pulmonary disease | Phase 3 Data readout | |
Blenrep (belantamab mafodotin) + BorDex Details Multiple myeloma | Phase 3 Data readout | |
Zejula Details Ovarian cancer, Solid tumor/s, Cancer, Platinum-resistant ovarian cancer | Phase 3 Data readout | |
Zejula Details Solid tumor/s, Cancer, Non-small cell lung carcinoma, Lung cancer | Phase 3 Data readout | |
Cobolimab Details Solid tumor/s, Non-small cell lung carcinoma, Cancer, Lung cancer | Phase 3 Data readout | |
Depemokimab Details Asthma | Phase 3 Update | |
Gepotidacin Details Prevention of gonorrhea | Phase 3 Update |